Vjhemonc Podcast

MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease

Informações:

Synopsis

Therapeutic agents for patients with myelodysplastic syndromes (MDS) are currently under active investigation in clinical trials. The management of cytopenias,... The post MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease appeared first on VJHemOnc.